Autism

MOVIA Robotics Welcomes Josias Reynoso to Its Team, Offering His Knowledge and Perspective as a Youth on the Autism Spectrum

Monday, June 14, 2021 - 1:44pm

is proud to welcome Josias Reynoso as the newest member of its growing team.

Key Points: 
  • is proud to welcome Josias Reynoso as the newest member of its growing team.
  • He brings with him to MOVIA his knowledge of robotics, coding and passion for teaching, as well as his own personal growth experience as a youth on the Autism Spectrum.
  • Josias will also be working on a MOVIA STEAM initiative to help expose children at a young age to coding and other STEAM related activities.
  • In addition, Josias will be engaging with customers to provide perspective and "hope" while on Zoom training calls and in person.

Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the Associated Professional Sleep Societies SLEEP 2021 Annual

Friday, June 11, 2021 - 5:30pm

Furthermore, the children with both DEE and autism spectrum disorder (ASD) showed more wide-ranging benefits on sleep compared to those with DEE alone.

Key Points: 
  • Furthermore, the children with both DEE and autism spectrum disorder (ASD) showed more wide-ranging benefits on sleep compared to those with DEE alone.
  • Epilepsy and sleep disorders have a bidirectional relationship and co-occur in individuals with ASD.
  • While these results are exploratory in nature, they are encouraging and warrant confirmation in future clinical trials of Zygel in patients with DEE and/or ASD.
  • Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release.

Unlocking the Genius of Autism -New School Opens in Riverhead

Friday, June 11, 2021 - 1:32pm

RIVERHEAD, N.Y., June 11, 2021 /PRNewswire/ --Acton Academy Eastern Long Island today announced the first phase of the Autism Studio launching July 6, 2021 in Riverhead, NY.

Key Points: 
  • RIVERHEAD, N.Y., June 11, 2021 /PRNewswire/ --Acton Academy Eastern Long Island today announced the first phase of the Autism Studio launching July 6, 2021 in Riverhead, NY.
  • It is a revolutionary new program that seeks to unlock this highly intelligent, grossly misunderstood population.
  • The Autism Studio, phase one, will begin this July, inviting non-speaking and minimally-speaking autistic individuals to learn S2C.
  • Andrea has published two books on autism, Autism A New Humanity (Hay House 2015) and Autism: A New Perspective (KDP 2019) which she co-authored with a non-verbal autist from Portugal.

Acorn Health Acquires LEAP Behavior Analysis in Tennessee

Thursday, June 10, 2021 - 3:38pm

Acorn Health, a national provider of Applied Behavior Analysis (ABA) therapy for children diagnosed with Autism Spectrum Disorder (ASD), is pleased to announce the acquisition of substantially all of the assets of LEAP Behavior Analysis (LEAP or the Company).

Key Points: 
  • Acorn Health, a national provider of Applied Behavior Analysis (ABA) therapy for children diagnosed with Autism Spectrum Disorder (ASD), is pleased to announce the acquisition of substantially all of the assets of LEAP Behavior Analysis (LEAP or the Company).
  • The Company is now a wholly-owned subsidiary of Acorn Health of Tennessee, and will operate under the Acorn Health brand.
  • We are excited to welcome LEAP into the Acorn Health network of high-quality ABA centers, said Vicki Kroviak, CEO of Acorn Health.
  • Acorn Health is a national provider of applied behavior analysis (ABA) therapy for children diagnosed with Autism Spectrum Disorder with locations in Michigan, Illinois, Virginia, Florida, Maryland, Pennsylvania, and Tennessee.

Joanne Garland's new book "A Pink Mountain: Like Mother, Like Son" is an inspirational memoir of a mother and son who both struggle with autism's stigmas and strife

Wednesday, June 9, 2021 - 5:00am

Joanne writes, "I guess it's ironic that a person with such a deep capacity for understanding others, especially those who are the most misunderstood would be so misunderstood herself.

Key Points: 
  • Joanne writes, "I guess it's ironic that a person with such a deep capacity for understanding others, especially those who are the most misunderstood would be so misunderstood herself.
  • But, as it appears to be, in my opinion, most, if not all people with some form of autism, are misunderstood by people who are, shall we say ignorant.
  • Published by Page Publishing, Joanne Garland's inspirational tale dives deeply into her personal struggles with the stigma attached to autism.
  • In her studies, Garland came to a chilling realization, the signals and situations speaking to her, that she too, was on the spectrum.

Autism Science Foundation’s Latest COVID-19 Grants Will Fund Studies Focusing on Telehealth and the Pandemic’s Mental Health Impacts

Monday, June 7, 2021 - 1:00pm

The mechanism was then expanded to include research about the unique effects of COVID-19 on people with autism.

Key Points: 
  • The mechanism was then expanded to include research about the unique effects of COVID-19 on people with autism.
  • Its also critical that we understand the unique mental health needs of people with autism who have been disproportionately impacted by the challenges and trauma of the pandemic.
  • Its mission is to support autism research by providing funding to scientists and organizations conducting autism research.
  • ASF also provides information about autism to the general public and serves to increase awareness of autism spectrum disorders and the needs of individuals and families affected by autism.

Molecules in Saliva May Hold the Key to Tracking Improvements in Autism

Thursday, June 3, 2021 - 8:35pm

SYRACUSE, N.Y., June 3, 2021 /PRNewswire/ --Molecules in the saliva may hold promise as a means to track the effectiveness of therapeutic interventions in children with autism spectrum disorder (ASD).

Key Points: 
  • SYRACUSE, N.Y., June 3, 2021 /PRNewswire/ --Molecules in the saliva may hold promise as a means to track the effectiveness of therapeutic interventions in children with autism spectrum disorder (ASD).
  • The results of this research was published in a paper titled "Longitudinal Stability of Salivary MicroRNA Biomarkers in Children and Adolescents with Autism Spectrum Disorder."
  • The prevalence of autism spectrum disorder has been consistently on the rise over the past few decades.
  • This novel approach in tracking RNA changes longitudinally in response to treatment can be another tool at the disposal of clinicians."

CentralReach Acquires Behaviorsoft, a Fast-Growing End-To-End EMR Platform Catering to the Needs of Small Applied Behavior Analysis Therapy Providers

Thursday, June 3, 2021 - 5:03pm

The acquisition further bolsters CentralReachs position as the market leader with solutions that are designed to fit the needs of every segment of the fast-growing market.

Key Points: 
  • The acquisition further bolsters CentralReachs position as the market leader with solutions that are designed to fit the needs of every segment of the fast-growing market.
  • We are thrilled to welcome the Behaviorsoft team and its co-founders, Carlos Horcasitas and Hector Gonzalez, to CentralReach, said CentralReach CEO Chris Sullens.
  • We couldnt think of a better fit than CentralReach to help propel Behaviorsofts solution to the next level.
  • CentralReach is a leading provider of EMR, practice management and clinical solutions that enable applied behavior analysis (ABA) and related behavioral health practices to deliver quality autism care for superior outcomes.

Zynerba Pharmaceuticals Announces Presentation of Efficacy and Safety Findings in Children and Adolescents with Autism Spectrum Disorder (ASD) and Related Disorders at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Thursday, June 3, 2021 - 3:00pm

ET in poster session II at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.

Key Points: 
  • ET in poster session II at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.
  • A copy of the poster is available on the Zynerba corporate website at http://zynerba.com/publications/ .
  • The poster titled, ZYN002 Cannabidiol Transdermal Gel: Efficacy and Safety Findings in Children and Adolescents With Autism Spectrum Disorder (ASD) and Related Disorders, shows that Zygel may provide important clinical promise across a spectrum of endpoints, including, behavior, seizure reduction and sleep.
  • The data are from two open-label Phase 2 trials and one double-blind placebo-controlled trial when added to standard of care in children and adolescents.

Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid

Wednesday, June 2, 2021 - 6:28pm

The AI-based device is the first FDA-authorized diagnosis aid designed to help physicians to diagnose autism in the primary care setting.

Key Points: 
  • The AI-based device is the first FDA-authorized diagnosis aid designed to help physicians to diagnose autism in the primary care setting.
  • While autism can be reliably diagnosed in children as early as 18 months, the average age of autism diagnosis has remained at 4 to 5 years old for decades.
  • Disparities in autism diagnosis are largely due to the lack of female and diverse representation in autism research to date.
  • The FDA marketing authorization has been granted following a successful pivotal study in which the device exceeded study endpoints.